With its modern facilities and trained staff of 1200, MN Pharmaceuticals is one of the leading manufacturers of Active Pharmaceutical Ingredients (API) and finished dosage forms.
MN Pharmaceuticals' finished dosage forms production facilities are located in Yenibosna, one of the main industrial areas of İstanbul. There are four separate plants for finished dosage forms on the same site. One of these plants is dedicated to penicillin-like beta-lactams and the other is dedicated to cephalosporin-like beta-lactams. The third plant "Other Products" plant is dedicated to non-penicillin and non-cephalosporin antibiotics and other products belonging to various therapeutic groups. The newest "Oncolytic Products" plant is dedicated to sterile liquid and freeze-dried injectable oncolytic products.
Production of all basic pharmaceutical forms at world standards is in accordance with the "Current Good Manufacturing Practices (cGMP)".
With its high-capacity of injectable units and lyophilization facilities, MN Pharmaceuticals is Turkey's most experienced pharmaceutical company in parenteral drug manufacturing.